mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.009 |